Resona Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Resona Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.8M	Sell	84,092 -6,220	-7%	-$2.76M	0.2%	92
2026 Q1	$40.3M	Buy	90,312 +913	+1%	+$426K	0.2%	99
2025 Q4	$40.6M	Sell	89,399 -2,699	-3%	-$1.16M	0.2%	96
2025 Q3	$36.1M	Sell	92,098 -4,351	-5%	-$1.82M	0.17%	114
2025 Q2	$42.9M	Buy	96,449 +5,687	+6%	+$2.62M	0.21%	99
2025 Q1	$44.1M	Buy	90,762 +4,535	+5%	+$2.11M	0.26%	81
2024 Q4	$34.8M	Sell	86,227 -7,976	-8%	-$3.7M	0.21%	95
2024 Q3	$43.8M	Sell	94,203 -2,475	-3%	-$1.19M	0.25%	78
2024 Q2	$45.4M	Sell	96,678 -4,803	-5%	-$2.08M	0.27%	68
2024 Q1	$42.4M	Buy	+101,481	New	+$42.9M	0.25%	81

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Resona Asset Management's VRTX Position: Q2 2026 in Review

Resona Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 6.9% in Q2 2026, selling an estimated $2.76M and leaving 84,092 shares worth $41.8M. The position accounts for 0.2% of the portfolio, ranked #92.

Resona Asset Management first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $45.4M in Q2 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Resona Asset Management held 84,092 shares of Vertex Pharmaceuticals worth $41.8M as of Q2 2026.
Resona Asset Management sold 6,220 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.76M.
Vertex Pharmaceuticals made up 0.2% of Resona Asset Management's portfolio in Q2 2026, its #92 holding.
Resona Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Resona Asset Management's Vertex Pharmaceuticals position peaked at $45.4M in Q2 2024.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.